Featured Image
Photo by Robina Weermeijer on Unsplash
Perspectives
During 90s, the country has a relatively low diabetes affected population. According to the International Diabetes Federation, the prevalence will be around 15% by 2030. With diabetes, the small blood vessels in the body are damaged. When the blood vessels in the kidneys are damaged, they cannot filter blood properly. About 30% of patients with Type 1 (juvenile onset) diabetes and 10%-40% of those with Type 2 (adult onset) diabetes undergo kidney failure. The primitive sign of diabetic kidney disease is an increased excretion of albumin in the urine. This happens long before the usual tests done after seeing a physician. DKD is a progressive condition and is the chief cause of ESRD as well as a risk factor for cardiovascular morbidity and mortality. There is general agreement that people with diabetes should be screened regularly to detect early markers of kidney damage. People with diabetes and microalbuminuria should be treated with a most factual arbitration to retard the progression of DKD.
Mr. Abdul Kader Mohiuddin
Read the Original
This page is a summary of: Domination of Nephrotic Problems among Diabetic Patients of Bangladesh, Archives of Nephrology and Urology, January 2018, Fortune Journals,
DOI: 10.26502/anu.2644-2833002.
You can read the full text:
Resources
Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management
Diabetic nephropathy (DN) or diabetic kidney disease refers to the deterioration of kidney function seen in chronic type 1 and type 2 diabetes mellitus patients. The progression of the disease is known to occur in a series of stages and is linked to glycemic and blood pressure control.
Diabetic kidney disease: A systematic review on the role of epigenetics as diagnostic and prognostic marker
Diabetic kidney disease is one of the most serious microvascular complications and among the leading causes of end stage renal disease. Persistently increasing albuminuria has been considered to be the central hallmark of nephropathy.
Identification of clinical predictors of diabetic nephropathy and non-diabetic renal disease in Chinese patients with type 2 diabetes, with reference to disease course and outcome.
To determine the prevalence of diabetic nephropathy (DN) and non-diabetic renal disease (NDRD) in patients with type 2 diabetes mellitus (T2DM), and the important clinical predictors of renal outcome and clinical course.
Contributors
The following have contributed to this page







